27/08/2026
We're excited to introduce BioQuasar by NYSCHEY LTD an AI-powered, GUI-based platform for accelerated NGS analysis.
Launching in January 2027, BioQuasar will support WGS/WES, RNA-seq, metagenomics, quality control, alignment, variant analysis and AI-generated reports.
Early-access, partnership and investment enquiries are welcome.